|
Volumn 96, Issue 10, 1999, Pages 5686-5691
|
Selective, covalent modification of β-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 FLUORO 1 METHOXY 4 PENTAFLUOROPHENYLSULFONAMIDOBENZENE;
ANTINEOPLASTIC AGENT;
BETA TUBULIN;
COLCHICINE;
DACTINOMYCIN;
DOXORUBICIN;
PACLITAXEL;
T 138067;
UNCLASSIFIED DRUG;
VINBLASTINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER RESISTANCE;
CELL STRAIN MCF 7;
CONTROLLED STUDY;
DRUG BINDING SITE;
HUMAN;
HUMAN CELL;
INTRAPERITONEAL DRUG ADMINISTRATION;
MALE;
MICROTUBULE;
MICROTUBULE ASSEMBLY;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
CYSTEINE;
CYTOSKELETON;
DRUG RESISTANCE, MULTIPLE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC;
MICE;
MICE, NUDE;
MICROTUBULES;
MOLECULAR STRUCTURE;
NEOPLASM TRANSPLANTATION;
PACLITAXEL;
PROTEIN BINDING;
SULFONAMIDES;
TUBULIN;
TUMOR CELLS, CULTURED;
VINBLASTINE;
ANIMALIA;
MUS MUSCULUS;
|
EID: 13044294012
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.96.10.5686 Document Type: Article |
Times cited : (173)
|
References (36)
|